Discontinuation report LEVEMIR FLEXTOUCH
Report ID | 182902 |
Drug Identification Number | 02412829 |
Brand name | LEVEMIR FLEXTOUCH |
Common or Proper name | LEVEMIR FLEXTOUCH 5X3 ML |
Company Name | NOVO NORDISK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | INSULIN DETEMIR |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | EA |
ATC code | A10AE |
ATC description | INSULINS AND ANALOGUES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-07-31 |
Actual discontinuation date | 2023-08-04 |
Remaining supply date | 2023-07-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Patients who continue to have coverage for Levemir® FlexTouch® formats have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-02-01 | English | Compare |
v2 | 2023-02-01 | French | Compare |
v3 | 2023-07-06 | English | Compare |
v4 | 2023-07-06 | French | Compare |
v5 | 2023-08-07 | English | Compare |
v6 | 2023-08-07 | French | Compare |
Showing 1 to 6 of 6